{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:15:58Z","timestamp":1790997358547,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejps.2021.105701","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T21:59:53Z","timestamp":1610402393000},"page":"105701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A new application of monosialotetrahexosylganglioside in pharmaceutics: preparation of freeze-thaw-resistant coenzyme Q10 emulsions"],"prefix":"10.1016","volume":"159","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105701_bib0001","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3109\/10837450.2014.898655","article-title":"Effect of lipid viscosity and high-pressure homogenization on the physical stability of \u201cvitamin E\u201d enriched emulsion","volume":"20","author":"Alayoubi","year":"2015","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2021.105701_bib0002","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s12035-015-9136-z","article-title":"GM1 ganglioside: past studies and future potential","volume":"53","author":"Aureli","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejps.2021.105701_bib0003","first-page":"497","article-title":"Optimization on the preparation of Cucurbitacin oral-lipid-nanoemulsion using central composite design-response surface methodology [in Chinese]","volume":"29","author":"Cheng","year":"2012","journal-title":"J. Shenyang Pharm. Univ."},{"key":"10.1016\/j.ejps.2021.105701_bib0004","first-page":"632","article-title":"Pharmacokinetics and tissue distribution of different particle sizes of CoQ10 emulsion and CoQ10 liposome in mice [in Chinese]","volume":"30","author":"Cheng","year":"2013","journal-title":"J. Shenyang Pharm. Univ."},{"key":"10.1016\/j.ejps.2021.105701_bib0005","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms21030868","article-title":"GM1 ganglioside is a key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration","volume":"21","author":"Chiricozzi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2021.105701_bib0006","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/1534735405276191","article-title":"Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity","volume":"4","author":"Conklin","year":"2005","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.ejps.2021.105701_bib0007","unstructured":"Deng, Y.H., Zhao, J., Dong, X.H., Shi, L., Lu, Y., Ni, D.M., Zhao, H.W., 2007. Composite type emulsifier, and emulsion prepared by using the emulsifier, and preparation method. CN Patent 101091890A."},{"key":"10.1016\/j.ejps.2021.105701_bib0008","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/156720205774962656","article-title":"The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardio- vascular disease, cancer and diabetes mellitus","volume":"2","author":"Dhanasekaran","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.ejps.2021.105701_bib0009","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2014.09.010","article-title":"Coenzyme Q10 and immunity: a case report and new implications for treatment of recurrent infections in metabolic diseases","volume":"155","author":"Farough","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2021.105701_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/bs.pmbts.2018.01.009","article-title":"Gangliosides in inflammation and neurodegeneration","volume":"156","author":"Furukawa","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejps.2021.105701_bib0011","first-page":"390","article-title":"Biological properties of coenzyme Q10 and its effects on immunity","volume":"142","author":"Gazd\u00edk","year":"2003","journal-title":"Cas. Lek. Cesk."},{"key":"10.1016\/j.ejps.2021.105701_bib0012","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1023\/B:PHAM.0000029280.39882.ff","article-title":"Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice","volume":"21","author":"Ishida","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2021.105701_bib0013","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jfoodeng.2007.03.007","article-title":"Production of sub-micron emulsions by ultrasound and microfluidization techniques","volume":"82","author":"Jafari","year":"2007","journal-title":"J. Food Eng."},{"key":"10.1016\/j.ejps.2021.105701_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0169-409X(00)00102-2","article-title":"Disposition characteristics of emulsions and incorporated drugs after systemic or local injection","volume":"45","author":"Kawakami","year":"2000","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2021.105701_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4939-8552-4_2","article-title":"Gangliosides of the nervous system","volume":"1804","author":"Ledeen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejps.2021.105701_bib0016","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jconrel.2012.07.031","article-title":"Self-assembled micelles of monosialogangliosides as nanodelivery vehicles for taxanes","volume":"162","author":"Leonhard","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2021.105701_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/02652049409040440","article-title":"Characterization of diazepam submicron emulsion interface: role of oleic acid","volume":"11","author":"Levy","year":"1994","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2021.105701_bib0018","first-page":"213","article-title":"The impact of lipid emulsions with different phospholipid\/triglyceride ratios on plasma lipid concentrations in the rats [in Chinese]","volume":"9","author":"Long","year":"2001","journal-title":"Chin. J. Clin. Nutr."},{"key":"10.1016\/j.ejps.2021.105701_bib0019","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0899-9007(99)00102-1","article-title":"The development of fat emulsions","volume":"15","author":"MacFie","year":"1999","journal-title":"Nutrition"},{"key":"10.1016\/j.ejps.2021.105701_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: treatment avenues in neurodegenerative disease","volume":"10","author":"Magistretti","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejps.2021.105701_bib0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0928-0987(01)00138-5","article-title":"Physicochemical characterisation of a drug-containing phospholipid-stabilised o\/w emulsion for intravenous administration","volume":"13","author":"Nord\u00e9n","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105701_bib0022","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ymgme.2008.04.012","article-title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects","volume":"94","author":"Pierri","year":"2008","journal-title":"Mol. Genct. Metab."},{"key":"10.1016\/j.ejps.2021.105701_bib0023","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1211\/0022357021779104","article-title":"Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel","volume":"54","author":"Rodrigues","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105701_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2003.12.022","article-title":"A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting","volume":"273","author":"Seki","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105701_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002639","article-title":"Coenzyme Q10 and heart failure: a state-of-the-art review","volume":"9","author":"Sharma","year":"2016","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ejps.2021.105701_bib0027","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Parkinson Study Group, Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejps.2021.105701_bib0028","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4103\/1673-5374.162950","article-title":"Neuroprotective effects of monosialotetrahexosylganglioside","volume":"10","author":"Xi","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ejps.2021.105701_bib0029","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(94)00188-B","article-title":"Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes","volume":"113","author":"Yamauchi","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105701_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cca.2015.08.002","article-title":"Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction","volume":"450","author":"Yang","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejps.2021.105701_bib0031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2006.01.019","article-title":"In vivo gene therapy of type \u2160 diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector","volume":"112","author":"Yoo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2021.105701_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1208\/s12249-019-1605-7","article-title":"Aprepitant intravenous emulsion based on ion pairing\/phospholipid complex for improving physical and chemical stability during thermal sterilization","volume":"21","author":"Zhang","year":"2020","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2021.105701_bib0033","first-page":"126","article-title":"Application of dynamic light scattering on the evaluation of the particles size and distribution of submicroemulsion for injection [in Chinese]","volume":"3","author":"Zheng","year":"2005","journal-title":"Chin. J. Pharm."},{"key":"10.1016\/j.ejps.2021.105701_bib0034","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1573403X14666180416115428","article-title":"Coenzyme Q10 in cardiovascular and metabolic diseases: current state of the problem","volume":"14","author":"Zozina","year":"2018","journal-title":"Curr. Cardiol. Rev."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:54:57Z","timestamp":1760529297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":33,"alternative-id":["S0928098721000038"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105701","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new application of monosialotetrahexosylganglioside in pharmaceutics: preparation of freeze-thaw-resistant coenzyme Q10 emulsions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105701"}}